The results showed that ZNF516 overexpression had a significant inhibitory effect on breast cancer cell proliferation, a phenotype that could be rescued by simultaneous overexpression of EGFR (Fig. 7a and Supplementary Fig. 4a, b). Here, ZNF516 is linked to breast cancer.